Asymmetric Dimethylarginine in Chronic Obstructive Pulmonary Disease (ADMA in COPD)

By Scott Jeremy A.   Duongh MyLinh   Young Aaron W.   Subbarao Padmaja   Gauvreau Gail M.   Grasemann Hartmut  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-04 ,pp. : 6062-6071

MDPI

Access to resources Recommend Favorite

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass

By Jacobi Johannes   Maas Renke   Arend Michaela   Cordasic Nada   Hilgers Karl F.  

International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-03 ,pp. : 5522-5535

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease

By Aldámiz-Echevarría Luis   Andrade Fernando  

International Journal of Molecular Sciences, Vol. 13, Iss. 9, 2012-09 ,pp. : 11288-11311

MDPI

Access to resources Recommend Favorite

Exogenous Asymmetric Dimethylarginine (ADMA) in Pathogenesis of Ischemia-Reperfusion-Induced Gastric Lesions: Interaction with Protective Nitric Oxide (NO) and Calcitonin Gene-Related Peptide (CGRP)

By Magierowski Marcin   Jasnos Katarzyna   Sliwowski Zbigniew   Surmiak Marcin   Krzysiek-Maczka Gracjana   Ptak-Belowska Agata   Kwiecien Slawomir   Brzozowski Tomasz  

International Journal of Molecular Sciences, Vol. 15, Iss. 3, 2014-03 ,pp. : 4946-4964

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases

By Dimitroulas Theodoros   Sandoo Aamer   Kitas George D.  

International Journal of Molecular Sciences, Vol. 13, Iss. 10, 2012-09 ,pp. : 12315-12335

MDPI

Access to resources Recommend Favorite